Effect of adalimumab on experimental corneal neovascularization model-Reference-Cited by-同舟云学术

Effect of adalimumab on experimental corneal neovascularization model

Published:2023-04-04 Issue:6 Volume:43 Page:2119-2128
ISSN:1573-2630
Container-title:International Ophthalmology
language:en
Short-container-title:Int Ophthalmol

Author:

Özkaya Dilek^ORCID,Karaca Umut,Usta Sofu Gülşah,Savran Mehtap,Özgöçmen Meltem,Ertuğrul Alper

Funder

Süleyman Demirel Üniversitesi

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s10792-023-02695-1.pdf

Reference38 articles.

1. Al-Debasi T, Al-Bekairy A, Al-Katheri A et al (2017) Topical versus subconjunctival anti-vascular endothelial growth factor (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization. Saudi J Ophthalmol 31:99–105

2. Azar DT (2006) Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol 104:264–302

3. Beebe DC (2008) Maintaining transparency: a review of the developmental physiology and pathophysiology of two avascular tissues. Semin Cell Dev Biol 19:125–133

4. Lee P, Wang CC, Adamis AP (1998) Ocular neovascularization: An epidemiologic review. Surv Ophthalmol 43:245–269

5. Kenyon BM, Voest EE, Chen CC et al (1996) A model of angiogenesis in the mouse cornea. Invest Ophthalmol 37:1625–1632

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of corneal neovascularization: Current and emerging therapeutic approaches;Indian Journal of Ophthalmology;2024-04-20

2. A Systematic Review of Tear Vascular Endothelial Growth Factor and External Eye Diseases;International Journal of Molecular Sciences;2024-01-23